Assessment of the licensing and patenting practices of UK's leading medical research institutions

Sarai Keestra made this Freedom of Information request to University of Southampton

This request has been closed to new correspondence from the public body. Contact us if you think it ought be re-opened.

Response to this request is long overdue. By law, under all circumstances, University of Southampton should have responded by now (details). You can complain by requesting an internal review.

Dear University of Southampton,

The FOI request below is being filed on behalf of UAEM-UK. Please note that the answers to these questions will be used to determine the university’s score in the forthcoming Global Health Ranking of leading UK universities by Universities Allied for Essential Medicines (UAEM) UK.

We encourage you to read this background briefing before compiling your response:
https://docs.google.com/document/d/1GMzH...

Thank you very much for your time & best wishes,
Sarai Keestra - Universities Allied for Essential Medicines UK

START FOI

For the purpose of clarity, please adhere to the following definitions when answering these questions:

Definitions

Low and middle income country: A country that is defined as ‘low’, ‘lower-middle’ and ‘upper-middle’ income by the World Bank for the year 2018. Income status defined by GNI per capita.
Source: World bank, available online [https://tinyurl.com/jr6s6fm]

Patent: A form of intellectual property (IP) rights protection, whereby a government grants to the inventor, the right to stop others from making, using or selling the product without their permission for a limited period.
Source: Upcouncil, available online [https://www.upcounsel.com/copyright-trad...

Licence: Contracts that transfer IP rights from the owner of the rights to a third party for use.
Source: Upcouncil, available online [https://www.upcounsel.com/copyright-trad...

Exclusive Licence: A licence that allows only the named licensee to exploit the relevant IP rights, the licensor is also excluded from exploiting these IP rights.
Source: TaylorWessing, available online [https://united-kingdom.taylorwessing.com...

Non-Exclusive Licence: A licence that grants any number of licensees to exploit the IP.
Source: TaylorWessing, available online [https://united-kingdom.taylorwessing.com...

Health Technology: ‘Health technology as defined by the WHO: “A health technology is the application of organized knowledge and skills in the form of devices, medicines, vaccines, procedures and systems developed to solve a health problem and improve quality of lives.’ Source: WHO, available online [http://www.who.int/health-technology-ass...

Q1. Has the university committed to licensing its medical discoveries in ways that promote access and affordability in Low- and Middle- Income Countries? If yes, please provide a link or PDF to the relevant policy document.

Q2. Please provide an Excel spreadsheet with headings as displayed below with all the health technologies LICENSED by the university in the past year AND specify which countries they were licensed in AND specify whether they are exclusive or non-exclusive licenses.

Health Technology Licensed | Country of Licensing | Type of License (Exclusive or Non-Exclusive)

Q3. Please provide an Excel spreadsheet with all the health technologies PATENTED by the university in the past year AND specify which countries they were patented in.

Q4.Has the university shared its best practices for promoting access to medicines through non-exclusive licensing by carrying out any of the following activities?
- Contributed sample clauses to the AUTM Global Health Toolkit
- Published an article, guidance, or other literature on access licensing practices
- Formally presented on access licensing practices at an academic or professional event, or at another university
- Informally shared or discussed access licensing practices with administrators at other universities
- Other
- None
(Tick as appropriate)

Q5. What actions has the technology transfer office (TTO) undertaken in the past year to improve access to the technologies they license in low- and middle-income settings?

END FOI

Yours faithfully,

Sarai Keestra

Support, University of Southampton

2 Attachments

Dear Sarai Keestra,

Freedom of Information Act 2000

Date of request: 09-10-2018 20:15:33 BST
Due date: 06-11-2018 20:15:33 GMT
Ref: RITM0138754

Acknowledgement of request for information

Thank you for your request for information dated 09-10-2018 20:15:33 BST,
a copy of which is appended hereto for your ease of reference.

The University will endeavour to respond as soon as practicable and in any
event by 06-11-2018 20:15:33 GMT. The reference for your request is
RITM0138754: please quote this reference in any future correspondence
regarding this request.

Requested information:

Dear University of Southampton, The FOI request below is being filed on
behalf of UAEM-UK. Please note that the answers to these questions will be
used to determine the university’s score in the forthcoming Global Health
Ranking of leading UK universities by Universities Allied for Essential
Medicines (UAEM) UK. We encourage you to read this background briefing
before compiling your response:
https://emea01.safelinks.protection.outl......
Thank you very much for your time & best wishes, Sarai Keestra -
Universities Allied for Essential Medicines UK START FOI For the purpose
of clarity, please adhere to the following definitions when answering
these questions: Definitions Low and middle income country: A country that
is defined as ‘low’, ‘lower-middle’ and ‘upper-middle’ income by the World
Bank for the year 2018. Income status defined by GNI per capita. Source:
World bank, available online
[https://emea01.safelinks.protection.outl...
Patent: A form of intellectual property (IP) rights protection, whereby a
government grants to the inventor, the right to stop others from making,
using or selling the product without their permission for a limited
period. Source: Upcouncil, available online
[https://emea01.safelinks.protection.outl......
Licence: Contracts that transfer IP rights from the owner of the rights to
a third party for use. Source: Upcouncil, available online
[https://emea01.safelinks.protection.outl......
Exclusive Licence: A licence that allows only the named licensee to
exploit the relevant IP rights, the licensor is also excluded from
exploiting these IP rights. Source: TaylorWessing, available online
[https://emea01.safelinks.protection.outl......
Non-Exclusive Licence: A licence that grants any number of licensees to
exploit the IP. Source: TaylorWessing, available online
[https://emea01.safelinks.protection.outl......
Health Technology: ‘Health technology as defined by the WHO: “A health
technology is the application of organized knowledge and skills in the
form of devices, medicines, vaccines, procedures and systems developed to
solve a health problem and improve quality of lives.’ Source: WHO,
available online
[https://emea01.safelinks.protection.outl......
Q1. Has the university committed to licensing its medical discoveries in
ways that promote access and affordability in Low- and Middle- Income
Countries? If yes, please provide a link or PDF to the relevant policy
document. Q2. Please provide an Excel spreadsheet with headings as
displayed below with all the health technologies LICENSED by the
university in the past year AND specify which countries they were licensed
in AND specify whether they are exclusive or non-exclusive licenses.
Health Technology Licensed | Country of Licensing | Type of License
(Exclusive or Non-Exclusive) Q3. Please provide an Excel spreadsheet with
all the health technologies PATENTED by the university in the past year
AND specify which countries they were patented in. Q4.Has the university
shared its best practices for promoting access to medicines through
non-exclusive licensing by carrying out any of the following activities? -
Contributed sample clauses to the AUTM Global Health Toolkit - Published
an article, guidance, or other literature on access licensing practices -
Formally presented on access licensing practices at an academic or
professional event, or at another university - Informally shared or
discussed access licensing practices with administrators at other
universities - Other - None (Tick as appropriate) Q5. What actions has the
technology transfer office (TTO) undertaken in the past year to improve
access to the technologies they license in low- and middle-income
settings? END FOI Yours faithfully, Sarai Keestra

Yours sincerely,

Freedom of Information Office

email: [University of Southampton request email]

 
Ref:MSG6708989

Dear University of Southampton,

It has been pointed out to me that the link to the background briefing in our FOI request was broken. Please accept my sincerest apologies for this inconvenience. This link should now be working: https://docs.google.com/document/d/1GMzH...

Yours sincerely,

Sarai Keestra

Dear University of Southampton,

Please pass this on to the person who conducts Freedom of Information reviews.

I am writing to request an internal review of University of Southampton's handling of my FOI request 'Assessment of the licensing and patenting practices of UK's leading medical research institutions'.
The time frame set by law for responding to this FOI request has expired and is currently 14 days (10 working days) overdue. I have not received any clarification as to why my FOI request has been delayed.

Please note that UAEM is planning to compile their global health ranking during the second half of December. The majority of the universities we sent FOI requests to have responded within the legal timeframe. We are therefore highly unlikely to be able to take into account information supplied after the 7th of December. We may be forced to score the university with 0 points on all dimensions if you cannot provide the information requested in our FOI by the 7th of December.

Therefore, I urge you to prioritise responding to this FOI request.

A full history of my FOI request and all correspondence is available on the Internet at this address:
https://www.whatdotheyknow.com/request/a...

Yours faithfully,

Sarai Keestra